このアイテムのアクセス数: 111

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
s41467-022-30429-x.pdf3.6 MBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.authorKobayashi, Takuyaen
dc.contributor.authorTsutsumi, Akihisaen
dc.contributor.authorKurebayashi, Nagomien
dc.contributor.authorSaito, Keien
dc.contributor.authorKodama, Masamien
dc.contributor.authorSakurai, Takashien
dc.contributor.authorKikkawa, Masahideen
dc.contributor.authorMurayama, Takashien
dc.contributor.authorOgawa, Haruoen
dc.contributor.alternative小林, 琢也ja
dc.contributor.alternative包, 明久ja
dc.contributor.alternative呉林, なごみja
dc.contributor.alternative斎藤, 慧ja
dc.contributor.alternative児玉, 昌美ja
dc.contributor.alternative櫻井, 隆ja
dc.contributor.alternative吉川, 雅英ja
dc.contributor.alternative村山, 尚ja
dc.contributor.alternative小川, 治夫ja
dc.date.accessioned2022-05-23T07:26:30Z-
dc.date.available2022-05-23T07:26:30Z-
dc.date.issued2022-
dc.identifier.urihttp://hdl.handle.net/2433/270377-
dc.description「てこ」と「ドミノ倒し」で巧妙に開くイオンの経路 --新規不整脈治療薬へ向けた手がかりを提示--. 京都大学プレスリリース. 2022-05-23.ja
dc.description.abstractCardiac ryanodine receptor (RyR2) is a large Ca²⁺ release channel in the sarcoplasmic reticulum and indispensable for excitation-contraction coupling in the heart. RyR2 is activated by Ca²⁺ and RyR2 mutations are implicated in severe arrhythmogenic diseases. Yet, the structural basis underlying channel opening and how mutations affect the channel remains unknown. Here, we address the gating mechanism of RyR2 by combining high-resolution structures determined by cryo-electron microscopy with quantitative functional analysis of channels carrying various mutations in specific residues. We demonstrated two fundamental mechanisms for channel gating: interactions close to the channel pore stabilize the channel to prevent hyperactivity and a series of interactions in the surrounding regions is necessary for channel opening upon Ca²⁺ binding. Mutations at the residues involved in the former and the latter mechanisms cause gain-of-function and loss-of-function, respectively. Our results reveal gating mechanisms of the RyR2 channel and alterations by pathogenic mutations at the atomic level.en
dc.language.isoeng-
dc.publisherSpringer Natureen
dc.rights© The Author(s) 2022en
dc.rightsThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.en
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/-
dc.subjectCalcium channelsen
dc.subjectCardiovascular biologyen
dc.subjectCryoelectron microscopyen
dc.subjectMembrane proteinsen
dc.subjectPermeation and transporten
dc.titleMolecular basis for gating of cardiac ryanodine receptor explains the mechanisms for gain- and loss-of function mutationsen
dc.typejournal article-
dc.type.niitypeJournal Article-
dc.identifier.jtitleNature Communicationsen
dc.identifier.volume13-
dc.relation.doi10.1038/s41467-022-30429-x-
dc.textversionpublisher-
dc.identifier.artnum2821-
dc.addressDepartment of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicineen
dc.addressDepartment of Cell Biology and Anatomy, Graduate School of Medicine, The University of Tokyoen
dc.addressDepartment of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicineen
dc.addressDepartment of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyoen
dc.addressDepartment of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicineen
dc.addressDepartment of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicineen
dc.addressDepartment of Cell Biology and Anatomy, Graduate School of Medicine, The University of Tokyoen
dc.addressDepartment of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicineen
dc.addressDepartment of Structural Biology, Graduate School of Pharmaceutical Sciences, Kyoto Universityen
dc.identifier.pmid35595836-
dc.relation.urlhttps://www.kyoto-u.ac.jp/ja/research-news/2022-05-23-
dcterms.accessRightsopen access-
datacite.awardNumber19K07105-
datacite.awardNumber22K06652-
datacite.awardNumber19H03404-
datacite.awardNumber22H02805-
datacite.awardNumber16H04748-
datacite.awardNumber21H02411-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-19K07105/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22K06652/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-19H03404/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22H02805/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-16H04748/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21H02411/-
dc.identifier.eissn2041-1723-
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.awardTitle不整脈治療薬としての2型リアノジン受容体阻害薬の有用性ja
jpcoar.awardTitleRyR2特異的な阻害薬、活性化薬の開発と抗不整脈薬としての応用ja
jpcoar.awardTitle新規リアノジン受容体作用薬を利用したサブタイプ特異的チャネル制御の分子機構ja
jpcoar.awardTitle新規再構成系を用いた骨格筋脱分極誘発性Ca2+遊離機構の解明ja
jpcoar.awardTitleカルシウムポンプによる組織特異的なカルシウムイオン制御機構の結晶学的解明ja
jpcoar.awardTitle心筋型リアノジン受容体のチャネル開口機構の構造的解明ja
出現コレクション:学術雑誌掲載論文等

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons